AMENDMENT NO. 3 TO JOINT DEVELOPMENT AND OPTION AGREEMENT BETWEEN THE CLEVELAND CLINIC FOUNDATION AND BREATHTECH CORPORATIONJoint Development and Option Agreement • September 20th, 2024 • ASTROTECH Corp • Laboratory analytical instruments • Delaware
This Amendment No. 3 to Joint Development and Option Agreement (this “Amendment”), is made and entered into effective as of November 21, 2023 (the “Amendment Date”), by and between The Cleveland Clinic Foundation (“CCF”) and BreathTech Corporation (“Company”, and together with CCF the “Parties”, and each, a “Party”).
First Amendment To Joint Development and Option AgreementJoint Development and Option Agreement • September 20th, 2024 • ASTROTECH Corp • Laboratory analytical instruments
This First Amendment ("Amendment") is made as of March 23, 2022 ("Amendment Effective Date") by and between The Cleveland Clinic Foundation, an Ohio non-profit corporation located at 9500 Euclid Avenue, Cleveland, Ohio 44195 (hereinafter referred to along with its Affiliates as "CCF"), and BreathTech Corporation, a wholly owned subsidiary of Astrotech Corporation (hereinafter referred to along with its Affiliates as "Company").
Amendment #1 to Investigator-Initiated Study AgreementInvestigator-Initiated Study Agreement • September 20th, 2024 • ASTROTECH Corp • Laboratory analytical instruments
This F Amendment #1 to the Investigator-Initiated Study Agreement(“Amendment #1”) is entered into as of the date of last signature and made effective as of November 15, 2022 (the “Effective Date”) by and between The Cleveland Clinic Foundation (“Institution”), an Ohio non-profit corporation with offices at 9500 Euclid Avenue, Cleveland, Ohio 44195, and BreathTech Corporation (“Company”) a wholly owned subsidiary of Astrotech Corporation with offices at 2028 E. Ben White Blvd. #240-9530, Austin, Texas 78741.
